|
Covance Announces Biomarker Expert Team Dedicated to Development, Validation, Testing of Biomarkers
|
| - World's largest biomarker testing company forms expert team to expedite biopharmaceutical customer need for high throughput assay services - (2007-04-27) |
|
|
Pfizer, Novartis, and AstraZeneca to give featured presentations at Oncology Biomarkers conference. |
| Kenna Anderes of Pfizer, Michael Shi of Novartis and Joseph Paul Eder of AstraZeneca to give featured presentations at Oncology Biomarkers: From Discovery to Validation conference January 2008. (2007-11-09) |
|
|
PPD expands Indian business |
| PPD (Wilmington, North Carolina) has appointed Dr Philip Mathew as director of strategic development , to lead its Phase II-IV operations and expansion in India. (2008-01-02) |
|
| Covance builds new US pre-clinical laboratory |
| Covance (Princeton, New Jersey) has purchased from Eli Lilly a partially constructed insulin manufacturing facility on a 47-acre site in Prince William County's technology park (Virginia, US). (2007-12-04) |
|
|
New gold standard for pharmacological and toxicological test systems developed. |
| Siam Life Science Secures Exclusive License For Unique Liver Cell Line From Premier U.S. Research Organization, Walter Reed Army Institute Of Research (2008-05-21) |
|
|
World Pharmaceutical Chemicals to 2005 - Market Size, Market Share,........ |
| The world market for pharmaceutical chemicals is analyzed in this study. It presents historical data and forecasts to 2005 and 2010 by therapeutic class (2007-04-27) |
|
|
Covance to Present at the 26th Annual Goldman Sachs Healthcare Conference |
| Covance to Present at the 26th Annual Goldman Sachs Healthcare Conference (2005-06-16) |
|
|
COVANCE INC. INVITES YOU TO JOIN THE WEBCAST OF ITS SECOND QUARTER 2005 FINANCIAL RESULTS CONFERENCE |
| COVANCE INC. INVITES YOU TO JOIN THE WEBCAST OF ITS SECOND QUARTER 2005 FINANCIAL RESULTS CONFERENCE CALL (2005-07-19) |
|
|
New Website Launched for ABS Laboratories Ltd |
| ABS Laboratories Ltd is pleased to announce the release of its web site www.abslabs.com developed by MSO.net. (2004-04-07) |
|
|
Covance Licenses Proprietary Innovative Clinical Solution from Oxford BioSignals Medical |
| Covance announced a strategic agreement with Oxford BioSignals Medical (OBS Medical) granting Covance exclusive rights within the CRO industry to OBS Medical's innovative BioQT(TM) clinical solutions. (2006-12-19) |
|
|
Covance Expands, Consolidates Research Clinic In Austin, TX |
| - New facility increases Phase I capacity - (2007-02-23) |
|
|
Covance Acquires Antibodies Product Line of Sternberger Monoclonals |
| Widely-known Products Extend Covance's Antibodies Suite for Neuroscience and Neurodegenerative Disease Research and Discovery (2005-07-07) |
|
|
Definiens Receives Frost & Sullivan Award for Technology Leadership in High Content Screening Market |
| Definiens, the number one Enterprise Image Intelligence™ company, today announced the receipt of Frost & Sullivan’s 2007 U.S. Award for Technology Leadership in the high-content screening market. (2007-09-17) |
|
| Keynote Speakers Announced for Modern Drug Summit |
| Executives from Wyeth Research, GlaxoSmithKline, Abbott Laboratories, Pfizer and the Former FDA Commissioner are announced as Keynote Speakers for the 2nd Modern Drug Discovery & Development Summit (M (2006-08-04) |
|
|
RAC concurs with US FDA on tgAAC94 |
| The US National Institutes of Health Recombinant DNA Advisory Committee has concurred with earlier conclusions that a patient death during a trial of Targeted Genetics’ injectable anti-arthritis drug , (2007-12-13) |
|
| GCT sets up Romanian office |
| Global Clinical Trials (Princeton, New Jersey), which conducts clinical trials in the former USSR and Eastern Europe, has opened a new office in Bucharest, Romania. (2008-01-02) |
|
|
Merck & Company to Present at GTCbio’s Targeted Designs for Clinical Trials Conference (July 19-20, |
| Dr. G. Frank Liu (Director, Vaccine Clinical Biostatistics at Merck & Company) will present at GTCbio’s Targeted Designs for Clinical Trials Conference on July 19-20, 2007 in Philadelphia, PA. (2007-05-10) |
|
| Quintiles expands Chinese facilities |
| Quintiles Transnational (Research Triangle Park, North Carolina) is to expand its global central laboratories and clinical development service (CDS) units in Beijing, China. (2008-01-16) |
|
|
Pharm-Olam Sponsors Seminars on Clinical Trials in India and Romania |
| HOUSTON, TEXAS May. 16, 2007. Pharm-Olam International Ltd. (POI), a multi-national, full service CRO to pharmaceutical and biotech industries will host complimentary seminars on conducting clinical t (2007-05-16) |
|
| MDS expands Chinese central labs |
| MDS Pharma Services (King of Prussia, Pennsylvania) has expanded its central lab operations in China, moving to a new, 25,000 sq ft facility near Beijing airport. (2007-11-08) |
|
|
Chiltern acquires US CRO CTMS |
| UK CRO Chiltern International (Slough, Berkshire) has acquired the independent US CRO Clinical Trial Management Services. Terms were not disclosed. (2007-11-26) |
|
| French ophthalmology CROs merge |
| Two French CROs specialising in ophthalmology, Iris Pharma and Clirophtha, have merged. The combined company will be known as Iris Pharma (2008-01-04) |
|
|
Robert Copeland, VP, Oncology Drug Discovery, GSK to give keynote talk at Cancer Drugs conference |
| Robert Copeland, VP of Biology, Oncology Center of Excellence in Drug Discovery at GlaxoSmithKline to give keynote presentation at 5th Cancer Drugs R&D conference on February 21-22, 2008 in Phoenix. (2007-11-09) |
|
|
Merck Serono to Present at GTCbio’s 2nd Assay Development & High Throughput Screening Conference (Ma |
| Dr. Dominique Perrin, Group Leader of Biochemical Pharmacology at Merck Serono International in Switzerland will give a presentation entitled “Phosphatases Inhibitors: from Screening to Biological Act (2007-05-03) |
|
| Provoke your sexual desire through tadalafil |
| The herbal tadalafil product Yixinjiaonang contained the prescription medicine tadalafil, also prescribed as an erectile dysfunction treatment. for more http://sexualhealth.blog.co.uk (2006-06-15) |
|
|
Clinical trials in computer. |
| New approach to computational toxicity and side effects prediction is recently reported. (2007-10-30) |
|
|
Dissolution Testing, Bioequivalence and Bioavailability Strategies |
| To be held at 26TH – 27TH JUNE 2008, BSG CONFERENCE CENTRE, LONDON, UK (2008-05-09) |
|
|
Obesity Meds and Research News (OMR) publishes a series of theme newsletters on weight loss drug dev |
| OMR has published a report on weight loss drug development . A series on developmental diabetes
drugs, and botanical and supplement research is planned for later in the year. (2005-04-13) |
|
|
Covance Relocates Research Facility In Honolulu |
| - Consolidated site provides access to key Asian population for bridge studies - (2006-11-21) |
|
|
India to host 30% of global clinical research by 2020 |
| India is expected to host 30% of the world's contract research within the next 10-15 years, driven by the attractions of low cost and high quality standards, says the India Brand Equity Foundation, IB (2007-10-22) |
|
| Indian and German CROs to merge |
| Indian CRO Manipal AcuNova (Bangalore) and its German counterpart ECRON (Frankfurt) have signed a definitive merger agreement. The combined company, ECRON AcuNova, will have 265 employees (2007-11-20) |
|
|
Merck & Newron start Phase III safinamide trial |
| Merck KGaA’s Merck Serono division and Newron Pharmaceuticals (Milan, Italy) have launched a Phase III trial of safinamide as an add-on to dopamine agonist therapy in early Parkinson’s disease. (2007-12-06) |
|
|
Cisbio and Lumiphore Announce Partnership for New Product and Technology Development |
| Cisbio and Lumiphore Announce Partnership for New Product and Technology Development Incorporating Lumi4â„¢ Compounds (2007-09-05) |
|
|
AURIGENE AND FOREST LABORATORIES TO COLLABORATE ON DEVELOPMENT OF NOVEL THERAPEUTICS FOR OBESITY |
| Aurigene and Forest announced today that the two companies have entered into a collaboration agreement to discover small molecule drug candidates for a novel obesity and metabolic disorders target (2007-02-02) |
|
| Australian Drug Development Surges Ahead |
| Innovation Dynamics today announced exciting new data revealing that over 450 drugs are in development by Australian biotechnology and pharmaceutical companies. (2008-01-29) |
|
|
LGC strengthens partnership with Gentris Corporation to market Human Genomic Reference Controls |
| LGC Promochem to market and distribute GentriSure™ product range in Europe and India
(2007-01-10) |
|
|
Appointment of LITMUS Molecular Design President |
| LITMUS LLC, a leading global technology innovations company, today announces that Dr. Bill W. Massey has been appointed as President of its wholly owned subsidiary, LITMUS Molecular Design (“LMD”). (2007-07-03) |
|
| Theranostics Report 2007-2012 |
| Key questions remain over theranostics. How can your company secure key successes and ideals in personalized medicine - aiming the right drug at the right person and at the right time. (2007-05-01) |
|
|
Gentris Corporation Announces New Addition to
Scientific Advisory Board
|
| Dr. Andrea Gaedigk of Children’s Mercy Hospital & Clinics joins advisory board of leading scientists
(2006-11-09) |
|
|
Nutra Pharma Announces Svizera Labs to Supply Designer Diagnostics' Test Kits to the World Health Or |
| Nutra Pharma Announces Svizera Labs to Supply Designer Diagnostics' Test Kits to the World Health Organization (2006-04-02) |
|
|
USC Marshall School of Business Announces Finalists for Asia-Pacific BioBusiness Leadership Award 20 |
| The USC Marshall School of Business today announced the finalists of the Asia-Pacific BioBusiness Leadership Award 2005 to be presented at its annual Asia-Pacific Business Outlook Conference on April (2005-03-14) |
|
|
Covance Promotes Luis T. Gutierrez, Jr. to President of Covance Commercialization Services |
| Covance Inc. (NYSE: CVD) today announced the promotion of Luis Gutierrez to the new role of President of Covance Commercialization Services. (2007-01-19) |
|
|
Up-and-Coming Strategic Marketing Firm Launches New
‘Marketing Audit and Key Messaging Service’ |
| New strategic marketing firm launches new marketing audit and key messaging service as well as new business branding book. (2007-05-03) |
|
|
COVANCE INCREASES ITS PHASE I CLINICAL CAPACITY WITH ACQUISITION OF GFI RESEARCH CENTER |
|
COVANCE INCREASES ITS PHASE I CLINICAL CAPACITY WITH ACQUISITION OF GFI RESEARCH CENTER (2005-08-30) |
|
|
Bio3 Research and Daxley Group Enter into License Agreement for Biocysan™ in End-Stage Renal Disease |
| Bio3 Research and Daxley Group Enter into License Agreement for Biocysan™ in End-Stage Renal Disease (2006-03-29) |
|
|
Cardiocore Sets Benchmark for Rapid Data Delivery in Thorough QT Trials
|
| Cardiocore Lab, Inc., a premier provider of centralized cardiac safety monitoring and analysis, announced an unprecedented achievement in electrocardiograph (ECG) data management. (2006-02-08) |
|
| Positive Phase II results for GSK’s malaria vaccine |
| Results from a Phase I/IIb trial of GlaxoSmithKline’s malaria vaccine, Mosquirix (RTS,S/AS02D), published in The Lancet, indicate that it is safe, well tolerated and immunogenic in African infants. (2007-10-22) |
|
|
Gentris Promotes Karen Nield to VP, Finance and Human Resources |
| Gentris Corporation (Gentris), a leading global provider of applied clinical pharmacogenomic services and diagnostic product solutions, today announced the promotion of Karen Nield to VP, Finance and (2006-09-14) |
|
| Seattle starts Phase IIb trial of SGN-40 |
| Seattle Genetics (Bothell, Washington) has begun a Phase IIb clinical trial of its monoclonal antibody SGN-40 as an adjunct to second-line therapy for relapsed or refractory diffuse large B-cell lymph (2007-12-10) |
|
|
EuroCapital BanCorp announces its first selection for it BioTech Fund |
| EuroCapital BanCorp, ECBC, announces that its BioTech Fund has selected two American BioTech companies to be its first selections for the fund. (2008-07-15) |
|
|
Herbal supplements the scepticism
|
| Many people nowadays are turning to “organics” and “naturals” otherwise known as herbals. The rising popularity of herbal supplements has created a new fad if not a new health lifestyle (2007-06-21) |
|
| TgAAC94 exonerated in US trial death |
| Targeted Genetics (Boston, Massachusetts) says that final tests support earlier indications that a patient death during a trial of its injectable anti-arthritis drug , tgAAC94, was not caused by the dr (2007-11-14) |
|
|
GSK declines option on Exelixis’s XL784 after Phase II results |
| GlaxoSmithKline has decided not to exercise its option to license Exelixis’s (San Francisco, California) kidney disease drug XL784 for further development and commercialisation. This follows the drug (2008-01-22) |
|
|
Veeda CR Installs India’s First Ever Clinical Pharmacology Unit For Renal Impaired Patients |
| VEEDA CR, India's fastest growing Clinical Research Organisation (CRO), today opened it's new Clinical Pharmacology Unit (CPU) at Muljibhai Patel Urological Hospital (MPUH), Nadiad, Gujarat. (2008-01-23) |
|
|
Restarting Tumor-Suppressor Gene May Fight Cancer |
| Manipulation of a gene that normally protects against malignancy but is switched off in cancer cells could open up a promising new frontier in research. (2007-01-25) |
|
|
COVANCE SUPPORTS CHINESE REGIONAL LABORATORY IN ACHIEVING LEVEL 1 NGSP CERTIFICATION
|
| Center of Laboratory Medicine, Hua Shan Hospital in Shanghai Distinguished as Only NGSP Level 1 Laboratory in China Linked to Global Clinical Trial Network (2005-07-19) |
|
|
NovaBay Pharmaceuticals Featured In November/December Issue of PharmaVOICE |
| Company Executives Offer “Crystal Ball� Predictions (2007-11-20) |
|
|
Choose the Drug Rehab Program That Suits You the Best |
| While selecting a drug and alcohol treatment program, you should consider the following: There are drug rehab centers that serve you by helping you medically and psychologically. In many patience opin (2007-11-03) |
|
|
Globepharm - eLearning |
| 30 years world-wide pharmaceutical industry expertise in all aspects of GMP compliance and quality assurance. Globepharm, healthcare,
manufacturing, API, api, BPC, bpc,active pharmaceutical ingred. (2006-11-22) |
|
| Generic Viagra | Cialis | Caverta | Silagra | Kamagra | Penegra | Meltabs |
| Generic Viagra, Caverta, Silagra, Edegra, Kamagra, Meltabs, Penegra, Generic Cialis, Generic Lipitor, Generic Propecia, Generic Allegra at Trustpharma.com Online Pharmacy Store. (2006-03-27) |
|
|
The Natural Way to Health Just Got Safer and More Secure! |
| Drug Natural was established by Darshana Vaishnav, a board certified medical doctor who has been practicing for over 20 years. (2008-01-11) |
|
| Replidyne stops bronchitis drug trial |
| Replidyne Inc. said it temporarily stopped a late-stage clinical trial of its respiratory infection drug after a regulatory panel said a comparator drug 's risks outweighed the benefits. (2006-12-26) |
|
|
Understanding Drug Use Interactive Cd-Rom (Drugs) |
| Introduction to contemporary understandings in psychoactive drugs. (2005-06-14) |
|
|
GTCbio’s 3rd Modern Drug Discovery and Development Summit |
| GTCbio announces its flagship event – the 3rd Modern Drug Discovery and Development Summit (M3D) on Nov. 28-30, 2007 in San Francisco – featuring 4 keynote speeches from top level execs at Pfizer (2007-10-09) |
|
|
Factors for Quality Drug and Alcohol Treatment Center |
| Your main purpose when entering an alcohol and drug rehabilitation center is to quit the habit of drinking and taking drugs. During that critical time you should be taken care of properly. Both medica (2007-11-03) |
|
